PROF vs RTX · rev $10.7M vs P/E 36, rev $88.60B
Profound Medical Corp (PROF) versus RTX Corporation (RTX) — a side-by-side from cached financials, not a winner call.
Profound Medical Corp (PROF) is a medical devices company listed on NASDAQ.
RTX Corporation (RTX) is a aerospace & defense company listed on NYSE. It is led by Chris Calio.
Latest reported PROF revenue for 2024-12-31 was $10.7M. Net income was -$27.8M. Revenue was up 48.4% from 2023-12-31 to 2024-12-31. PROF currently screens at market cap $238.7M.
Latest reported RTX revenue for 2025-12-31 was $88.60B. Net income was $6.73B. Revenue was up 9.7% from 2024-12-31 to 2025-12-31. RTX currently screens at market cap $259.34B and trailing P/E 36.2.
PROF currently screens at market cap $238.7M. RTX currently screens at market cap $259.34B and trailing P/E 36.2.
Not investment advice. Open the PROF and RTX stock pages for the full models.
Not investment advice.